Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament for treating vital myocarditis and cardiomyopathy

A technology for viral myocarditis and cardiomyopathy, applied in the directions of antiviral agents, drug combinations, pharmaceutical formulations, etc., can solve the problems of unsatisfactory treatment effect of myocarditis, poor efficacy of arrhythmia, affecting the treatment of myocarditis, etc., and achieves ideal treatment effect, Significant curative effect and low recurrence rate

Inactive Publication Date: 2013-05-29
CHENGDU JIANJIANG PHARMA FACTORY
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the therapeutic effect of Western medicine on myocarditis is not satisfactory.
For patients with viral myocarditis, there are few effective antiviral drugs in Western medicine, which affects the treatment of myocarditis
Also less effective against arrhythmias in patients with chronic myocarditis
Especially cardiomyopathy, the cause is still unknown, and there is no good treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] The present embodiment is the method for preparing pills.

[0027] Take 8 parts of Astragalus, 6 parts of Panax notoginseng, and 4 parts of leeches;

[0028] 4 parts of Ophiopogon japonicus, 5 parts of Schisandra chinensis, 8 parts of Ginseng, 5 parts of honeysuckle, 2 parts of rhodiola;

[0029] 3 parts of Poria cocos, 2 parts of Chuanxiong, 3 parts of red peony, 3 parts of loofah, 2 parts of wheat, 5 parts of jujube kernel, 3 parts of Baiziren, 4 parts of Wulingzhi, 3 parts of Puhuang, 3 parts of saffron, and 3 parts of polygala ;

[0030] Amber 2 parts.

[0031] Steam in boiling water at 100°C for 60 minutes, spread to cool and then dry in the sun. Grind the above raw materials into fine powder and mix evenly. Mix and stir with honey water with a weight of honey: water = 9: 1, and coat with cinnabar to make a pill.

Embodiment 2

[0033] This embodiment is a method for preparing an aqueous solution.

[0034] Take 12 parts of Astragalus, 610 parts of Panax notoginseng, and 8 parts of leeches;

[0035] 8 parts of Ophiopogon japonicus, 10 parts of Schisandra chinensis, 12 parts of Ginseng, 10 parts of honeysuckle, 4 parts of rhodiola;

[0036] 6 parts of Poria cocos, 4 parts of Chuanxiong, 6 parts of red peony, 6 parts of loofah, 6 parts of wheat, 8 parts of jujube kernel, 6 parts of Baiziren, 8 parts of Wulingzhi, 8 parts of Puhuang, 6 parts of saffron, and 6 parts of polygala ;

[0037] 4 parts of amber, 2 parts of cinnabar.

[0038] Add water that is 5 times the weight of the medicinal materials used and boil it. After boiling on a high fire, change it to a slow fire and boil it for 20 minutes, filter it out, and repeat three times. Mix the three water preparations and take according to the dosage of ordinary Chinese medicine.

Embodiment 3

[0040] This embodiment is a method for preparing tablets.

[0041] Take 10 parts of Astragalus, 8 parts of Panax notoginseng, and 6 parts of leeches;

[0042] 6 parts of Ophiopogon japonicus, 8 parts of Schisandra chinensis, 10 parts of Ginseng, 8 parts of honeysuckle, 3 parts of rhodiola;

[0043] 5 parts of Poria cocos, 3 parts of Chuanxiong, 5 parts of red peony root, 4 parts of loofah, 5 parts of wheat, 6 parts of jujube kernel, 4 parts of Baiziren, 5 parts of Wulingzhi, 6 parts of Puhuang, 5 parts of saffron, and 5 parts of polygala ;

[0044] 3 parts of amber, 2 parts of cinnabar.

[0045] Steam in boiling water at 100°C for 60 minutes, spread to cool, and then dry in the sun. Grind the above raw materials into fine powder, mix evenly, and press into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicament for treating vital myocarditis and cardiomyopathy. The medicament consists of the following medicaments in parts by weight: 8 to 12 parts of astragalus root, 6 to 10 parts of pseudo-ginseng, 4 to 8 parts of leech, 4 to 8 parts of dwarf lilyturf tuber, 5 to 10 parts of schisandra, 8 to 12 parts of glehnia root, 5 to 10 parts of honeysuckle, 2 to 4 parts of rhodiola, 3 to 6 parts of poria cocos, 2 to 4 parts of Szechuan lovage rhizome, 3 to 6 parts of red peony root, 3 to 6 parts of loofah sponge, 2 to 6 parts of wheat, 5 to 8 parts of jujube kernel, 3 to 6 parts of platycladi seed, 4 to 8 pats of trogopterus dung, 3 to 8 parts of typhae pollen, 3 to 6 parts of saffron, 3 to 6 parts of polygala root, 2 to 4 parts of amber, and 1 to 2 parts of cinnabar. The medicament has the effects of diminishing inflammation, clearing fire, tonifying heart, enriching blood, soothing nerves and tonifying qi, and has a remarkable treatment effect on myocarditis, insufficiency of heart blood, myocardial strain, angina pectoris, worry beyond measure, panic and amnesia, mind restlessness and the like.

Description

technical field [0001] The invention relates to a medicine for treating heart diseases, in particular to a medicine for treating viral myocarditis and cardiomyopathy. Background technique [0002] Myocarditis refers to localized or diffuse acute, subacute or chronic inflammatory lesions in the myocardium. Generally speaking, myocarditis is viral myocarditis caused by viral infection. In recent years, the relative incidence of viral myocarditis has been increasing. The severity of the disease is different, and the manifestations are very different. Infants and young children are more serious, and adults are more mild. Mild cases may have no obvious symptoms, and severe cases may be complicated by severe arrhythmia. Heart failure or even sudden death. [0003] Cardiomyopathy (DDM) is a group of lesions that cause progressive cardiac dysfunction due to structural changes in the ventricles and impaired myocardial wall function. Its clinical manifestations include cardiac enla...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P9/00A61P31/12A61K33/28A61K35/10A61K35/24A61K35/62
Inventor 张强
Owner CHENGDU JIANJIANG PHARMA FACTORY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com